MAI Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
MAI Capital Management's AMLX Position: Q3 2026 in Review
MAI Capital Management opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 9,051 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #1619 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in AMLX as recently as Q1 2026.
MAI Capital Management first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- MAI Capital Management held 9,051 shares of Amylyx Pharmaceuticals worth $263K as of Q3 2026.
- Amylyx Pharmaceuticals was a new MAI Capital Management position in Q3 2026.
- Amylyx Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q3 2026, its #1619 holding.
- MAI Capital Management first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.